Well, if they don't get the S-1 filed soon, NGIO won't be getting listed this year.
We have yet to hear of the CV results with the peptide testing, sooooo.
We have yet to hear of the signing of any of the deals, soooo.
We are already in mid September.
While it has been frustrating, we are already in Mid September and what have we accomplished so far? We are still waiting to hear back on things which is the same thing shareholders have been having to do on everything for over a year. It just seems like nothing has changed here. A lot of talk with no results.
This is starting to get really old now. It's September 14th and we have nothing to show for anything. No results, no signed documents, no S-1. Nothing.
Generex Biotechnology Corp. (GNBT) Stock Research Links